Population | Sample | Score | Phenotype | STS marker | Position (cM) | References (year) |
---|---|---|---|---|---|---|
Japanese | 224 ASP in 159 families, 359 individuals | 1.57 MLS | T2D | D15S994 | 40.25 | Mori Y et al. 2002 [11] |
 |  | 3.91 MLS | T2D (Young-onset < 45) | D15S994 | 40.25 |  |
 |  | 2.44 MLS | T2D (BMI < 30) | D15S994 | 40.25 |  |
 |  | 1.50 MLS | T2D | D15S118 | 32.58 |  |
 |  | 0.95 MLS | T2D | D15S117 | 51.21 |  |
Japanese | 256 ASP in 164 families, 368 individuals | 2.41 LOD | T2D (BMI < 22) | CYP19 | 45.62 | Iwasaki N et al. 2003 [12] |
Japanese | 102 ASP in 102 families | 0.25 LOD | T2D | D15S117 | 51.21 | Nawata H et al. 2004 [13] |
Mexican Americans | 330 ASP in 170 families, 408 individuals | 1.50 MLS | T2D | D15S119 | 45.62 | Hanis CL et al. 1996 [14] |
Pima Indians | 388 ASP in 109 families, 363 individuals | 1.46 LOD | insulin secretion (IVGTT 10) | D15S659 | 43.47 | Pratley RE et al. 1998 [15] |
Mexican Americans | 330 ASP in 170 families and 363 nondiabetic individuals | 1.27 LOD | T2D | D15S119 | 45.62 | Cox NJ et al. 1999 [16] |
 | interaction with D15S119 and CYP19 | 4.00 LOD | T2D | D15S119+ CYP19 |  |  |